Online registration for this event is now closed. If you would like to register for this event, please contact Customer Service at (800) 892-1400, Option 2.

Developed in cooperation with AACC’s Proteomics & Molecular Pathology Divisions, The National Cancer Institute & The National Heart, Lung and Blood Institute

This program will focus on the essential knowledge required for discovery of viable biomarkers of human disease and the transition of those markers from R&D to clinical use. Topics to be presented include new and emerging proteomic technologies; proteomics-focused initiatives from NCI and NHLBI; regulatory of new proteomic devices in the U.S.; and issues in applied clinical proteomics.